Pennsylvania has granted 23 new retail licenses for the second stage of its medical marijuana program; among the winners were a few public companies in the space.

On Tuesday (December 18), the Pennsylvania Department of Health confirmed the new cannabis licenses had been granted, allowing the winners to go operational within the next six months.


Among the public companies awarded licenses were Cresco Labs (CSE:CL), Harvest Health & Recreation (CSE:HARV), MedMen Enterprises (CSE:MMEN) and Green Thumb Industries (CSE:GTII).

MedMen secured its spot on the list by way of its blockbuster all-stock acquisition of PharmaCann for a price of US$682 million.

Harvest was awarded six licenses, one in each area indicated by the Pennsylvania Department of Health. Right next to it was GTI, which won four licenses total. PharmaCann got two licenses and Cresco obtained only one in the state.

Each license awarded grants the companies the option to open three marijuana dispensaries.

During the phase one stage of the retail rollout in June 2017, GTI and Cresco had already secured one retail license each.

This week GTI had also secured new licenses for retail operations in New Jersey.

Steve White, founder and CEO of Harvest, said in a statement to shareholders Pennsylvania had exceeded their expectations as a cannabis market, adding it has risen as one of the most important states for the company’s operations.

Similar to its neighboring state of New Jersey, the Pennsylvania Department of Health has divided different sections for companies to apply and gain licenses.

However, unlike New Jersey, Pennsylvania didn’t block the same company from obtaining multiple licenses in different areas.

Pennsylvania secretary of health Dr. Rachel Levine said the phase of two of the dispensary rollout will give more options to consumers.

“This step continues the growth of our scientific, medically-based medical marijuana program,” Dr. Levine said.

According to the local government agency, once all these new dispensaries are open, Pennsylvania will have 79 total shops.

Pennsylvania has over 98,000 patients who have registered for the state medical marijuana program, with over 66,000 currently owning identification cards making them available to purchase legal product.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 Matica Enterprises Inc. (CSE: MMJ) (OTCQB: MMJFF) (FSE: 39N) (“Matica” or the “Company”) reports the Company has granted 6,500,000 stock options exercisable at $0.05 for five years from date of grant. These include 4,000,000 options to two officers (who are also directors) and, 2,500,000 to two consultants.

For more information on Matica Enterprises please visit the website at: www.maticaenterprises.com.

Keep reading... Show less

The Company welcomes adult-use customers at its eight dispensaries across the state and will create 120 new jobs in surrounding communities

– Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, today announced it will begin serving adult-use consumers across its eight dispensaries in Arizona .

Keep reading... Show less

Harvest Health & Recreation Inc. (“Harvest”) (CSE: HARV, OTCQX: HRVSF), a vertically integrated cannabis company and multi-state operator in the U.S., today announced the launch of recreational cannabis sales in Arizona .

Keep reading... Show less

Jason Mitchell Co-Founder, Director and Chief Executive Officer, HempFusion Wellness Inc. (“HempFusion” or the “Company”) (TSX: CBD.U), and his team joined David Chelich Sector Head, Global Energy and Diversified Industries, TMX Group, to celebrate the Company’s new listing on Toronto Stock Exchange and open the market.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it is one of the seventeen companies in the U.S. and Canada that will be included in the First Psychedelics Exchange Traded Fund, which is managed by Horizons ETF Management.

The Horizons Psychedelic Stock Index ETF index is expected to start trading on Tuesday, January 26, under the ticker PSYK on the NEO exchange.

Keep reading... Show less